The pathobiological features of gastrointestinal cancers (Review)

Oncology Letters

Volumn 3, Issue 5, 2012, Pages 961-969

  Yang, Xue ^a   Takano, Yasuo ^b   Zheng, Hua Chuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b KANAGAWA CANCER CENTER   (Japan)

Author keywords

Gastrointestinal carcinomas; Immunohistochemistry; In situ hybridization; Pathobiological behaviors; Pathogenesis; Prognosis; Tissue microarray

Indexed keywords

ACTIN RELATED PROTEIN 2; ACTIN RELATED PROTEIN 3; AURORA A KINASE; BETA1 INTEGRIN; CD147 ANTIGEN; CD82 ANTIGEN; CORTACTIN; EOSIN; FASCIN; FRAGILE HISTIDINE TRIAD PROTEIN; GELATINASE A; GELATINASE B; GUANINE NUCLEOTIDE BINDING PROTEIN; HEMATOXYLIN; HISTONE ACETYLTRANSFERASE; MASPIN; MATRILYSIN; MOLECULAR MARKER; MUCIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; TENASCIN;

ANGIOGENESIS; CANCER INVASION; CELL ADHESION; CELL MOTILITY; CLINICAL FEATURE; DISEASE COURSE; ENDOPLASMIC RETICULUM STRESS; GASTROINTESTINAL CARCINOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINE EPITHELIUM; MALIGNANT TRANSFORMATION; MICROWAVE IRRADIATION; MOLECULAR MECHANICS; PATHOGENESIS; PATHOLOGY; PROTEIN EXPRESSION; REVIEW; STOMACH CARCINOMA; TISSUE MICROARRAY; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

EID: 84863241310     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.628     Document Type: Review

References (38)

1. Kelley JR and Duggan JM: Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56: 1-9, 2003.
2. American Cancer Society. Colorectal cancer facts and figures 2005.
3. Moch H, Schraml P, Bubendorf L, Mirlacher M, Kononen J, Gasser T, Mihatsch MJ, Kallioniemi OP and Sauter G: High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol 154: 981-986, 1999.
4. Kumada T, Tsuneyama K, Hatta H, Ishizawa S and Takano Y: Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol 17: 1141-1149, 2004.
5. Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Murai Y, Nomoto K and Takano Y: An immunohistochemical study of P53 and Ki-67 in gastrointestinal adenoma and adenocarcinoma using tissue microarray. Anticancer Res 26: 2353-2360, 2006.
6. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Tsuneyama K and Takano Y: Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings. Appl Immunohistochem Mol Morphol 15: 432-440, 2007.
7. Li XH, Zheng HC, Takahashi H, Masuda S, Yang XH and Takano Y: PTEN expression and mutation in colorectal carcinomas. Oncol Rep 22: 757-764, 2009.
8. Xing YN, Yang X, Xu XY, Zheng Y, Xu HM, Takano Y and Zheng HC: The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression. Hum Pathol 42: 25-35, 2011.
9. Zheng HC, Xia P, Xu XY, Takahashi H and Takano Y: The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas. Hum Pathol 42: 424-433, 2011.
10. Zheng HC, Takahashi H, Li XH, Hara T, Masuda S, Guan YF and Takano Y: Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Virchows Arch 452: 147-155, 2008.
11. Zheng HC, Wei ZL, Xu XY, Nie XC, Yang X, Takahashi H and Takano Y: Parafibromin expression is an independent prognostic factor for colorectal carcinomas. Hum Pathol 8: 1089-1102, 2011.
12. Lee JH, Park SR, Chay KO, Seo YW, Kook H, Ahn KY, Kim YJ and Kim KK: KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumour metastasis suppressor, and enhances metastasis of cancer. Cancer Res 64: 4235-4243, 2004.
13. Schoenfeld N, Bauer MK and Grimm S: The metastasis suppressor gene C33/CD82/KAI1 induces apoptosis through reactive oxygen intermediates. FASEB J 18: 158-160, 2004.
14. Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Nomoto K, Murai Y and Takano Y: Expression of KAI1 and tenascin, and microvessel density are closely correlated with liver metastasis of gastrointestinal adenocarcinoma. J Clin Pathol 60: 50-56, 2007.
15. Maass N, Hojo T, Ueding M, Luttges J, Kloppel G, Jonat W and Nagasaki K: Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Clin Cancer Res 7: 812-817, 2001.
16. Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA and Hendrix MJ: The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 8: 2924-2932, 2002.
17. Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K and Kawamoto M: Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Ann Thorac Surg 79: 248-253, 2005.
18. Ito Y, Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Matsuura N, Kuma K and Miyauchi A: Maspin expression is directly associated with biological aggressiveness of thyroid carcinoma. Thyroid 14: 13-18, 2004.
19. Sugimoto S, Maass N, Takimoto Y, Sato K, Minei S, Zhang M, Hoshikawa Y, Junemann KP, Jonat W and Nagasaki K: Expression and regulation of tumor suppressor gene maspin in human bladder cancer. Cancer Lett 203: 209-215, 2004.
20. Yu M, Zheng H, Tsuneyama K, Takahashi H, Nomoto K, Xu H and Takano Y: Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression. Hum Pathol 38: 1248-1255, 2007.
21. Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Murai Y, Nomoto K and Takano Y: Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors. Anticancer Res 27: 259-265, 2007.
22. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Niwa H, Tsuneyama K and Takano Y: Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 26: 3579-3583, 2006.
23. Zheng HC, Sun JM, Li XH, Yang XF, Zhang YC and Xin Y: Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma. Pathol Int 53: 659-666, 2003.
24. Zheng HC, Wang W, Xu XY, Xia P, Yu M, Sugiyama T and Takano Y: Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level. J Cancer Res Clin Oncol 137: 585-596, 2011.
25. Zheng HC, Takahashi H, Murai Y, Cui ZG, Nomoto K, Miwa S, Tsuneyama K and Takano Y: Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Br J Cancer 95: 1371-1378, 2006.
26. Li X, Zheng H, Hara T, Takahashi H, Masuda S, Wang Z, Yang X, Guan Y and Takano Y: Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Int J Oncol 33: 69-79, 2008.
27. Zheng HC, Zheng YS, Li XH, Takahashi H, Hara T, Masuda S, Yang XH, Guan YF and Takano Y: Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma. Anticancer Res 28: 2225-2232, 2008.
28. Takahashi H, Wang JP, Zheng HC, Masuda S and Takano Y: Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis. Histol Histopathol 26: 663-671, 2011.
29. Zheng HC, Takahashi H, Li XH, Hara T, Masuda S, Guan YF and Takano Y: Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Hum Pathol 39: 1042-1049, 2008.
30. Zheng HC, Xu XY, Xia P, Yu M, Takahashi H and Takano Y: Involvement of inactive GSK3beta overexpression in tumorigenesis and progression of gastric carcinomas. Hum Pathol 41: 1255-1264, 2010.
31. Zheng HC, Tsuneyama K, Takahashi H, Miwa S, Sugiyama T, Popivanova BK, Fujii C, Nomoto K, Mukaida N and Takano Y: Aberrant Pim-3 expression is involved in gastric adenoma adenocarcinoma sequence and cancer progression. J Cancer Res Clin Oncol 134: 481-488, 2008.
32. Li XH, Zheng HC, Wang ZG, Takahashi H, Yang XH, Guan YF and Takano Y: The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays. Anticancer Res 28: 1061-1067, 2008.
33. Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, Tsuneyama K and Takano Y: MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays. J Cancer Res Clin Oncol 132: 817-823, 2006.
34. Zheng HC, Xu XY, Yu M, Takahashi H, Masuda S and Takano Y: The role of Reg IV gene and its encoding product in gastric carcinogenesis. Hum Pathol 41: 59-69, 2010.
35. Zheng HC, Sugawara A, Okamoto H, Takasawa S, Takahashi H, Masuda S and Takano Y: Expression profile of the REG gene family in colorectal carcinoma. J Histochem Cytochem 59: 106-115, 2011.
36. Zheng H, Takahashi H, Murai Y, Cui Z, Nomoto K, Miwa S, Tsuneyama K and Takano Y: Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray. J Clin Pathol 60: 273-277, 2007.
37. Zheng HC, Li XH, Hara T, Masuda S, Yang XH, Guan YF and Takano Y: Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas. Virchows Arch 452: 525-534, 2008.
38. Zheng HC, Zheng YS, Xia P, Xu XY, Xing YN, Takahashi H, Guan YF and Takano Y: The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes. Histol Histopathol 25: 445-452, 2010.